Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Curegene Pharmaceutical Co., Ltd.

Clinical trials sponsored by Shanghai Curegene Pharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New plavix rival enters human testing Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New plavix rival enters human testing

Disease control Recruiting now

This early-stage trial compares a new investigational drug, CG-0255, to the established blood thinner Plavix in 136 healthy adults aged 18-55. The goal is to see if CG-0255 is processed by the body similarly to Plavix and has the same effect on preventing blood clots. Participant…

Phase 1 • Sponsor: Shanghai CureGene Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC